Five-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement-the ARISE Study and ARISE Registry Data.
Alexander HorkeIgor TudoracheGünther LauferMartin AndreasJose Luis PomarDaniel PeredaEduard QuintanaMarta SitgesBart MeynsFilip R RegaMark HazekampRobert CesnjevarMartin Oliver SchmiadyJohn PepperUlrich RosendahlArtur LichtenbergDmytro StadnikRamadan JashariDietmar BoethigDmitry BobylevMurat AvsarArjang RuhparwarAxel HaverichSerghei CebotariSamir SarikouchPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)
The 5-year results of the prospective multicentre ARISE trial continue to show DAH to be safe for aortic valve replacement with excellent haemodynamics.
Keyphrases
- aortic valve replacement
- transcatheter aortic valve implantation
- study protocol
- aortic stenosis
- aortic valve
- clinical trial
- phase iii
- phase ii
- transcatheter aortic valve replacement
- ejection fraction
- randomized controlled trial
- electronic health record
- left ventricular
- big data
- heart failure
- double blind
- extracellular matrix
- cross sectional
- machine learning
- artificial intelligence
- deep learning